
|Articles|October 1, 2016
- Pharmaceutical Executive-10-01-2016
- Volume 36
- Issue 10
Pharmaceutical Executive, October 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Content Marketing’s Data Fail: Information Without Insight?over 9 years ago
The Rise of the CFO Strategist: Balancing Numbers and Know-howalmost 10 years ago
Steps Toward Rare Disease Successalmost 10 years ago
‘Huge Sellers’ Herald Changes in Japan Drug Pricingalmost 10 years ago
Real-World Evidence: From Volume to Valuealmost 10 years ago
Pharma and the Peril of Europe’s Trade Policiesalmost 10 years ago
New Challenge to IP Innovationalmost 10 years ago
Major Changes Ahead for Drug User Feesalmost 10 years ago
Country Report: Czech RepublicAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5




